Showing results (121-130 of 506) with videos related to

Sort By:
Pageof 51
Scientific Reports|September 16, 2017
An omniphobic lubricant-infused coating produced by chemical vapor deposition of hydrophobic organosilanes attenuates clotting on catheter surfacesMaryam Badv, Iqbal H Jaffer, Jeffrey I Weitz, et al.
Thrombosis and Haemostasis|September 6, 2006
Initial treatment of venous thromboembolismCecilia Becattini, Giancarlo Agnelli, Joseph Emmerich, et al.
Blood|January 30, 2010
Structure and function of factor XIJonas Emsley, Paul A McEwan, David Gailani
Pediatric Blood & Cancer|August 19, 2011
Acquired factor XI deficiency in a child with membranoproliferative glomerulonephritisMeghann Pine McManus, Christopher Frantz, David Gailani
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Murine models in the evaluation of heparan sulfate-based anticoagulantsDavid Gailani, Qiufang Cheng, Ivan S Ivanov
Blood|June 4, 2021
The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trialChristina U Lorentz, Erik I Tucker, Norah G Verbout, et al.
European Journal of Haematology|March 14, 2018
Screening and diagnostic clinical algorithm for paroxysmal nocturnal hemoglobinuria: Expert consensusAlexander Röth, Jaroslaw Maciejewski, Jun-Ichi Nishimura, et al.
Biophysical Chemistry|December 2, 2004
Modes and consequences of thrombin's interaction with fibrinJames C Fredenburgh, Alan R Stafford, Caroline H Pospisil, et al.
Kidney International|October 3, 2021
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic targetJohn Eikelboom, Jürgen Floege, Ravi Thadhani, et al.
Expert Review of Cardiovascular Therapy|May 24, 2018
Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with bioprosthetic valvesJason G Andrade, Elena Meseguer, Romain Didier, et al.
Pageof 51